[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension]

MeSH terms

• Administration, Oral
• Antihypertensive Agents / adverse effects
• Antihypertensive Agents / therapeutic use*
• Bosentan
• Drug Therapy, Combination
• Endothelin Receptor Antagonists*
• Europe
• Evidence-Based Medicine*
• Humans
• Hypertension, Pulmonary / classification
• Hypertension, Pulmonary / drug therapy*
• Isoxazoles / adverse effects
• Isoxazoles / therapeutic use
• Phenylpropionates / adverse effects
• Phenylpropionates / therapeutic use
• Phosphodiesterase 5 Inhibitors
• Phosphodiesterase Inhibitors / therapeutic use
• Piperazines / adverse effects
• Piperazines / therapeutic use
• Practice Guidelines as Topic
• Purines / adverse effects
• Purines / therapeutic use
• Pyridazines / adverse effects
• Pyridazines / therapeutic use
• Sildenafil Citrate
• Sulfonamides / adverse effects
• Sulfonamides / therapeutic use
• Sulfones / adverse effects
• Sulfones / therapeutic use
• Thiophenes / adverse effects
• Thiophenes / therapeutic use